Brand Name

Carafate

Generic Name
Sucralfate
View Brand Information
FDA approval date: October 30, 1981
Classification: Aluminum Complex
Form: Tablet, Suspension

What is Carafate (Sucralfate)?

Sucralfate tablets, USP are indicated in: Short-term treatment of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.

Approved To Treat

Top Global Experts

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

Alginate vs Sucralfate for GERD Symptomatic Relief in Combination With PPIS
Alginate vs Sucralfate for GERD Symptomatic Relief in Combination With PPIS
Enrollment Status: Recruiting
Publish Date: March 19, 2026
Intervention Type: Drug
Study Phase: Phase 2/Phase 3

Summary: Gastroesophageal reflux disease (GERD) is a chronic gastrointestinal disorder characterized by the regurgitation of gastric contents into the esophagus.It can also present in an atypical manner such as chest pain, dental erosions, chronic cough, laryngitis, or asthma i.e. extra gastroesophageal symptoms. Sucralfate is a unique anti-ulcer drug and is a basic aluminum salt of sucrose octa-sulfate. I...

Prevention of Post-sphincterotomy Bleeding by Endoscopic Tranexamic Acid and Sucralfate Administration: A Randomized Controlled Trial
Prevention of Post-sphincterotomy Bleeding by Endoscopic Tranexamic Acid and Sucralfate Administration: A Randomized Controlled Trial
Enrollment Status: Recruiting
Publish Date: May 25, 2025
Intervention Type: Drug
Study Phase: Not Applicable

Methods: This is a randomized clinical trial. Patients with choledocholithiasis scheduled for ERCP with EST at National Cheng Kung University Hospital and Siriraj Hospital were enrolled. The study will recruit 120 patients. After randomization, 60 patients will be classified into the intervention group and 60 into the control group. The participants will receive standard ERCP and EST for common bile duct s...

View All Clinical Trials

Related Latest Advances

Polyphenolic profile and gastroprotective effect of Jatropha multifida Linn leaves against ethanol-induced gastric ulcer in rats: Involvement of the NLRP3/caspase-1/GSDMD pyroptotic pathway.
Polyphenolic profile and gastroprotective effect of Jatropha multifida Linn leaves against ethanol-induced gastric ulcer in rats: Involvement of the NLRP3/caspase-1/GSDMD pyroptotic pathway.
Journal: Journal of ethnopharmacology
Published: February 15, 2026
Topical tranexamic acid and sucralfate prevent delayed bleeding after endoscopic sphincterotomy: a randomized controlled trial (with video).
Topical tranexamic acid and sucralfate prevent delayed bleeding after endoscopic sphincterotomy: a randomized controlled trial (with video).
Journal: Therapeutic advances in gastroenterology
Published: December 18, 2025
Endoscopic application of tranexamic acid and sucralfate in upper gastrointestinal bleeding: A randomized controlled trial.
Endoscopic application of tranexamic acid and sucralfate in upper gastrointestinal bleeding: A randomized controlled trial.
Journal: Clinical and translational gastroenterology
Published: December 03, 2025
View All Latest Advances